• Users Online: 90
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2019  |  Volume : 13  |  Issue : 2  |  Page : 83-90

Quality of life in Turkish patients with autoimmune blistering diseases: Reliability and validity of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires


1 Department of Dermatology, St. George Hospital, University of New South Wales, Sydney, NSW, Australia
2 Department of Dermatology and Venereology, Faculty of Medicine, Akdeniz University, Antalya, Turkey
3 Departments of Statistics, Faculty of Mathematics and Statistics, Sydney University, Sydney, NSW, Australia

Correspondence Address:
Dr. Asli Bilgic-Temel
Department of Dermatology, St. George Hospital, University of New South Wales, 17 Kensington Street, Kogarah, Sydney, NSW 2217
Australia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/TJD.TJD_16_19

Rights and Permissions

Background: The Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment of Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires, which are specific for autoimmune blistering diseases (AIBDs), were developed in Australia. Aims and Objectives: The aim of this study was to validate the Turkish version of the ABQOL and TABQOL questionnaires and to assess the reliability of them in the Turkish population. Materials and Methods: The Turkish versions of the ABQOL and TABQOL questionnaires were produced by forward–backward translation of the original English version. The patients were requested to complete ABQOL and TABQOL questionnaires on day 0 and after 7 days for a 2nd time sent by post. Furthermore, patients also completed other health-related quality of life scales on day 0. Results: A total of 68 patients with AIBDs were recruited. A subset of 20 (29.4%) patients completed the day 7 questionnaire. Both the Turkish versions of the ABQOL and TABQOL questionnaires had a high internal consistency (0.86 and 0.88, respectively) and test–retest reliability (0.87 and 0.87, respectively). The correlation between ABQOL and TABQOL scores was moderate (Pearson's R = 0.609). Conclusion: We have shown that the Turkish versions of ABQOL and TABQOL questionnaires are valid and reliable instruments. They can be used to measure treatment burden in Turkish AIBD patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1794    
    Printed95    
    Emailed0    
    PDF Downloaded253    
    Comments [Add]    

Recommend this journal